Results 151 to 160 of about 34,547 (259)
This TriNetX (US, 2016–2023) study compared clinical outcomes in patients with rheumatoid arthritis and type 2 diabetes treated with GLP‐1 receptor agonists vs DPP4 inhibitors. ABSTRACT Objectives To evaluate whether glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) are associated with improved survival and renal outcomes in patients with ...
Yu‐Ting Yu +4 more
wiley +1 more source
In adolescents with type 1 diabetes, the arterial triple‐line pattern (TLP) signals early lower extremity vascular remodeling. Low‐grade albuminuria (UACR ≥15 mg/g) independently predicts TLP, supporting the combined use of these markers to identify subclinical atherosclerosis.
Jung‐Chi Hsu +7 more
wiley +1 more source
ABSTRACT Background and Aims Metabolic dysfunction‐associated steatohepatitis (MASH) with cirrhosis lacks definitive treatments and poses an increasing healthcare burden globally. We undertook a systematic literature review (SLR) to better understand the disease burden in cirrhosis due to MASH.
Hannes Hagström +8 more
wiley +1 more source
From Cure to Complexity: Post‐SVR Liver and Metabolic Trajectories in Diabetic Patients
ABSTRACT Background and Aims The long‐term impact of HCV cure on hepatic and metabolic outcomes in patients with type 2 diabetes (T2D) remains insufficiently defined. This study evaluated T2D‐related vascular complications, liver disease progression and overall survival over 9 years of follow‐up, also exploring genetic variability contribution ...
Clelia Asero +14 more
wiley +1 more source
Engineering of marker‐free lettuce chloroplast genome to express CTB‐Exenatide and CTB‐Lixisenatide for oral delivery. Upper panel: Chemically synthesised exenatide or lixisenatide require expensive production, purification, refrigeration and invasive delivery methods.
Rahul Singh, Henry Daniell
wiley +1 more source
Abstract Glomerular podocytes play a key role in the pathogenesis of diabetic kidney disease (DKD). Recent studies suggest that natriuretic peptides (NPs) are podocyte protective. The beneficial effects of NPs are inhibited by the removal of NPs from the circulation by the NP clearance receptor (NPRC).
Liming Wang +4 more
wiley +1 more source
Associations between glycated albumin and current measures of glycaemic control in Saudi adults. [PDF]
Bahijri S +6 more
europepmc +1 more source
Diabetes, Obesity and Metabolism, Volume 28, Issue 5, Page 4400-4404, May 2026.
Hiddo J. L. Heerspink +11 more
wiley +1 more source
Effect of elevated body mass index on glycated albumin levels in healthy individuals. [PDF]
Uysal S, Erdenen F.
europepmc +1 more source

